NKX2-5 and pulmonary arterial hypertension: Previous research has demonstrated the association between NKX2-5 mutations/knockdown with ASD, atrioventricular conduction blocks, pulmonary hypertension, and hyperplastic atria, supporting its status as a downstream target of STX18-AS1 [28].